Dr. Smita Pattanaik
Designation : Professor
Department : PHARMACOLOGY

 
 
 :: Contact Details
  Phone No.    :   7087008104
  Ext No.        :   5265
 :: Educational Qualification
  Graduation :   MBBS from Utkal Univeristy in year 2000
  Post Graduation :   MD Pharmacology from PGIMER Chandigarh in year 2005
  Other Qualification.(1)      :   DNB in Pharmacology from National Board of Examination New Delhi in year 2006
  Other Qualification.(2)      :   DM Clinical Pharmacology from PGIMER Chandigarh in year 2009
     
 :: Area of Interest
       Area Of Interest       :

At this this point of my career I intend to concentrate on the following research themes:


1) Clinical pharmacology of immunosuppressant drugs.

2) Therapeutic Drug Monitoring and dose individualization (PK/PD) modeling and pharmacogenomics.

3) Clinical Research Methodology and Biostatistics.

4) Clinical Pharmacology of genitourinary system.

5) Bladder Cancer Chemotherapy.
     
 :: Research & Projects
      Extramural Projects       :

As a principle investigator:

1. Exploring the utility of urine-based cell culture in the management of bladder cancer (Extramural- DBT-RGYI 2012: INR 19.8 lakhs, completed in 2016).

2. A Phase II/III Clinical Trial Evaluating Efficacy and Safety of Hydroxychloroquine in Combination with Gemcitabine and Cisplatin in Muscle Invasive Urothelial Carcinoma of Urinary Bladder (Extramural- funded by DST-SERB in Sept 2018: INR 25lakhs,)

3. Development of a Novel Buccal Drug Delivery system for Tacrolimus for the patients with renal transplantation, BIRAC-BIG (48.9 Lakhs, 2020)

As a co-investigator

1. Correlation between Pre-transplant Tacrolimus Single-Dose Trough Concentrations and Post-Transplant Steady State Trough Concentrations (Co-PI/ UT DST/ sanctioned 97000/Jan 2019).

2. Correlation between AUC of mycophenolate mofetil and its gastrointestinal tolerability in renal transplant recipients (Co-PI/ UT DST/ sanctioned 98000/Jan 2019).

3.  Development of an Intelligent Blood Extraction Device. Ravimohan SM (PI), Smita Pattanaik(Co-PI), Harpreet Singh (Co-PI). funding by ICMR

Projects approved as PI or Co-PI ( funding awaited)

1. Medical Application based PostStroke care Strategy (MOBILITY trial) for survivors and their caregivers: A Randomized ControlledTrial. Dheeraj Khurana (PI), Smita Pattanaik (Co-PI), Ashok Kumar (Co-0PI) MulticentricClinical Trial approved by ICMR for funding in 2020, Tentative approval ofbudget upto 1.25 crores for 3 years )

2. Biotechnology Ignition Grant (BIG-15competition cycle). BIRAC/FITT0689/BIG-15/19.Smita Pattanaik (PI), AshishSharma (Co-I), V R Sinha (Co-I), Tentative grant amount upto 50 lakhs and duration of project is 18 months.
      Departmental / P.G.I.
      Projects      		 :

1.    1.Mycophenolic Acid Exposure in Lupus Nephritis to Standard Clinical Dose and its Correlation to Therapeutic Response and Adverse Events (Intramural-PGIMER sanctioned in 2017: INR 4.89 lakhs, Completed.

       2. Exploring the Distribution of the known Pharmacogenetic Determinants of Tacrolimus Pharmacokinetics in the patients with de novo Renal Transplantation at PGIMER (Co-PI/Intramural-PGIMER/ funds sanctioned in 2018: 5.0 lakhs, Completed)

    3. Pharmacokinetic-PharmacodynamicCorrelation of Intravenously Administered Polymyxin-B in patients with Acinetobacter boumannii Infection(Intramural-PGIMER).

      4. Erectiledysfunction and statin therapy: A cross-sectional, observational study toelucidate a possibility of association (Intramural-PGIMER).
      Research In
      Progress      		 :

  1. AUC controlled mycophenolate mofetil versus conventional dosing in patients with de novo renal transplantation (ongoing project)

  2. Study of the pharmacogenomic determinants of tacrolimus disposition in patients with de-novo renal transplantation to individualize the dosing ( PhD thesis)

  3. Pharmacodynamic markers of immunosuppression in patients with renal transplantation and their correlation with the outcome (ongoing PhD thesis)

  4. Anticancer potential of ALDH antagonist in Transitional Cell carcinoma of the urinary bladder (ongoing PhD thesis)

  5. Cannabinoid receptor modulators as potential therapeutic targets in renal cell cancer (ongoing PhD thesis)

      Area Of
      Specialization      		 :

1. Clinical Pharmacology of Immunosuppressant and Anticancer Drugs

2. Therapeutic Drug Monitoring, Model Informed Precision Dosing and Pharmacogenomics

3. Clinical Research Methodology, Biostatistics and Clinical Trials

4. Clinical Pharmacology of drugs acting on the Genitourinary system

5. Drug repositioning for cancer chemotherapy resistance
      Future Plans       :

I intend to concentrate on developing an ‘integrated patient care and research’ model at our centre.
      Awards & Honours       :

  1. Honoured as an invited Alumni to the panel discussion (virtual mode) in the eighth ‘Global Clinical Scholars Research Training program 2020-21’ on 4th Dec 2020 hosted by the Harvard Medical School Boston, United States of America.

  2. Awarded the Paul Dudley White International Scholar award as a recognition for the authors with the highest ranked abstract from India at the International Stroke Conference of the American Heart Association at Los Angeles, USA on 20th May 2020   

  3. Awarded the Best Paper-First Prize of the Indian Journal of Urology for the year 2019 for the paper Indian J Urol. 2019;35:25-33 and a plaque to honour this achievement at the  Annual meeting of Urological Society of India USICON 2020 at Kochi.

  4. Awarded the Best researcher in the category of Additional Professors in the 7th Annual Institute Research Day, for publishing high quality research in the Institute Research Appreciation Program on PGIMER Annual Research Day on 5th October 2019.

  5. Awarded with travel grant and invited as a speaker to talk on “TDM in India” in the symposium “TDM is Asia” to the World congress of Therapeutic Drug Monitoring and Clinical Toxicology held at Kyoto, Japan 23rd-27th Sept 2017.

  6. Serving on the board of International Editors of the British Journal of Clinical Pharmacology of the British Pharmacological Society for a period of 5 years (August 2016 to July 2021)

  7. ‘Eagle Eye Award’ from the Editors of Goodman and Gillman Pharmacological Basis of Therapeutics; June 2016.

  8. Awarded the Fulbright-Nehru Academic and Professional Excellence Fellowship for 2014-2015, under the mentorship of Prof. James C Ritchie, Emory Clinical and Translational Research Laboratory of the Emory University School of Medicine and Emory University. Could be found at ( http://www.usief.org.in/INF-2014-15/Academic-and-Professional-Excellence-Scholars/Smita-Pattanaik.html)

  9. Awarded Full Scholarship for the ‘Global Clinical Scholars Research Training program 2013-14’ by the Harvard Medical School Boston, United States of America. Could be found at  (http://hms.harvard.edu/departments/global-clinical-scholars-research-training-program/gcsrt-program-scholarships)

  10. Awarded Distinction for the CAPSTONE proposal in the ‘Global Clinical Scholars Research Training program 2013-14’ by the Harvard Medical School Boston, United States of America.

  11. Awarded the Best researcher in the category of Assistant Professors in the second Institute foundation day Research Appreciation Program in 2013.

  12. Best Outgoing Student of the district and 23rd best student in Orissa in the State Senior Secondary School Examination batch of 1991. 

      Member Of Professional
      Bodies      		 :

Affiliation and membership of professional societies

1.     Life member of Indian Pharmacological Society (IPS)

2.     Member of Indian Society of Rational Pharmacotherapeutics (ISRPT)

3.     Member National Academy of Medical Sciences (MNAMS)

4.     Member International Medical sciences Academy (IMSA)

5.     Indian Society of Organ Transplantation (ISOT)

6.     Member of British Pharmacological Society (BPS)

7.     Member of American College of Clinical Pharmacology (ACCP)

8.  Member of International Association of Therapeutic Drug Monitoring and  Toxicology(IATDMCT) Immunosuppressive and Anticancer Drugs Committee

9.   Councillor, International Association of Therapeutic Drug Monitoring and Toxicology (IATDMCT)


Peer Reviewer and Editorial board of scientific journals

Reviewer:

1.     British Journal of Clinical Pharmacology

2.     Journal of Cardiovascular Drugs and Therapy

3.     Journal of Pharmacology and Pharmacotherapeutics

4.     International Journal of Basic and Applied Medical Research.

5.     Indian Journal of Urology

6.     Toxicology and Industrial Health.

7.     Phytotherapy Research

     Editor:

1.   International Editorial Board, British Journal of Clinical Pharmacology (2016-2021)

2.   Executive Editor, British Journal of Clinical Pharmacology (2022-2027)

3. Editor-in-Chief of Compass, International Association of Therapeutic Drug Monitoring and Toxicology (IATDMCT)
     
 :: Publications(In Vancouver Style)

Title and details

IF

Citations

Altmetric Score

Kumar A, Khurana D, Pattanaik S, Kumar M, Kaur S, Krishnan NC et. al. A mobile application based post-stroke care strategy for survivors and their caregivers for prevention and management of post-stroke complications – “ stroke Home Care.” Development and Feasibility.

 

J neuroscience  Rural Practioce doi: 10.25259/JNRP_411_2023

-

 

 

Yadav A, Kumar R, Dayal D, Yadav J, Pattanaik S, Patil A. Effect of Postmeal Fast-Acting Insulin Aspart Injection on the Frequency of Hypoglycemia among Pre-School Children with Type 1 Diabetes: An Open-Label, Cross-Over, Randomized Control Trial.

 

Indian J Pediatr. 2023 Oct 21. doi: 10.1007/s12098-023-04844-x. Epub ahead of print. PMID: 37863869.

3.8

 

 

Pattanaik S, Gota V, Tripathi SK, Kshirsagar NA. Therapeutic Drug Monitoring in India: A SWOT Analysis. Br J Clin Pharmacol. 2023 May 31. doi: 10.1111/bcp.15808. Epub ahead of print. PMID: 37259249.

 

4.6

 

 

Pattanaik S, Patil AN, Kumaravel J and Prakash G (2022) Therapeutic drug monitoring for cytotoxic anticancer drugs: Principles and evidence-based practices. Front. Oncol. 12:1015200. doi: 10.3389/fonc.2022.1015200

 

6.2

 

 

U-DAVIS-Deep Learning Based Arm Venous Image Segmentation Technique for Venipuncture. Computational Intelligence and Neuroscience, vol. 2022, Article ID 4559219, 2022. https://doi.org/10.1155/2022/4559219.

 

3.633

 

 

Therapeutic drug monitoring and dosage adjustments of immunosuppressive drugs when combined with nirmatrelvir/ritonavir in patients with COVID-19

Lemaitre, Florian; Budde, Klemens; Van Gelder, Teun; Bergan, Stein; Lawson, Roland; Noceti, Ofelia; Venkataramanan, Raman; Elens, Laure; Moes, Dirk Jan A.R.; Hesselink, Dennis A.; Pawinski, Tomasz; Johnson-Davis, Kamisha L.; De Winter, Brenda C.M.; Pattanaik, Smita; Brunet, Mercè; Masuda, Satohiro; Langman, Loralie J.

Therapeutic Drug Monitoring: August 09, 2022 - Volume - Issue - 10.1097/FTD.0000000000001014

doi: 10.1097/FTD.0000000000001014

 

2.073

 

 

Shanker Kasudhan K, Patial A, Mehra N, Verma Attri S, Malhotra P, Pattanaik S, Lad D, Patil AN. Cyclophosphamide, hydroxycyclophosphamide and carboxyethyl phosphoramide mustard quantification with liquid chromatography mass spectrometry in a single run human plasma samples: A rapid and sensitive method development. J Chromatogr B Analyt Technol Biomed Life Sci. 2022 Mar 30;1198:123228. doi: 10.1016/j.jchromb.2022.123228. Epub ahead of print. PMID: 35385800.

 

3.148

 

 

Rana A, Singh H, Mavuduru R, Pattanaik S, Rana PS. Quantifying prognosis severity of COVID-19 patients from deep learning based analysis of CT chest images. Multimed Tools Appl. 2022 Mar 8:1-25. doi: 10.1007/s11042-022-12214-6. Epub ahead of print. PMID: 35282403; PMCID: PMC8901869.

 

2.393

 

 

Grover S, Kasudhan KS, Murali N, Patil AN, Pattanaik S, Chakrabarti S, Avasthi A. Pharmacometabolomics-guided clozapine therapy in treatment resistant schizophrenia: Preliminary exploration of future too near. Asian J Psychiatr. 2022 Jan;67:102939. doi: 10.1016/j.ajp.2021.102939. Epub 2021 Nov 24. PMID: 34844176.

 

3.543

 

 

Zahan S, Sahu JK, Madaan P, Suthar R, Pattanaik S, Saini AG, Saini L, Kumar A, Sankhyan N. Effectiveness and Safety of Nitrazepam in Children with Resistant West Syndrome. Indian J Pediatr. 2022 Jan;89(1):37-44. doi: 10.1007/s12098-021-03823-4. Epub 2021 Jun 24. PMID: 34169452.

 

1.508

 

 

Dalui SK, Chakraverty R, Yasmin N, Pattanaik S, Pandit K, Chatterjee S. Effects of DPP4 Inhibitors on Renal Outcomes in Diabetes Mellitus: A Systematic Review and Meta-Analysis. Indian J Endocrinol Metab. 2021 Jul-Aug;25(4):283-292. doi: 10.4103/ijem.ijem_237_21. Epub 2021 Dec 15. PMID: 35136733; PMCID: PMC8793961.

 

0.456

 

 

Banerjee A, Sahu JK, Sankhyan N, Pattanaik S, Suthar R, Saini AG, Saini L, Negi S, Malhi P, Singhi P. Randomized trial of high-dose pyridoxine in combination with standard hormonal therapy in West syndrome. Seizure. 2021 Oct;91:75-80. doi: 10.1016/j.seizure.2021.05.012. Epub 2021 May 29. PMID: 34118609

https://doi.org/10.1016/j.seizure.2021.05.012

2.522

-

-

Maheswari N, Panda NB, Mahajan S,

Luthra A, Pattanaik S, Bhatia N, Karthigeyan M, Kaloria N, Chauhan R, Soni S, Jangra K, Hemant Bhagat H.

 

Ketofol as an Anesthetic Agent in Patients with Isolated

Moderate to Severe Traumatic Brain Injury: A Prospective,

Randomized Double-blind Controlled Trial

 

J Neurosurg Anesthesiol 2021;00:000–000

DOI: 10.1097/ANA.0000000000000774

3.238

-

-

Bergan S, Brunet M, Hesselink DA, Johnson-Davis KL, Kunicki PK, Lemaitre F, Marquet P, Molinaro M, Noceti O, Pattanaik S, Pawinski T, Seger C, Shipkova M, Swen JJ, van Gelder T, Venkataramanan R, Wieland E, Woillard JB, Zwart TC, Barten MJ, Budde K, Dieterlen MT, Elens L, Haufroid V, Masuda S, Millan O, Mizuno T, Moes DJAR, Oellerich M, Picard N, Salzmann L, Tönshoff B, van Schaik RHN, Vethe NT, Vinks AA, Wallemacq P, Åsberg A, Langman LJ.

 

Personalized Therapy for Mycophenolate: Consensus

Report by the International Association of Therapeutic Drug

Monitoring and Clinical Toxicology.

 

Ther Drug Monit. 2021 Apr 1;43(2):150-200.

doi: 10.1097/FTD.0000000000000871.

 

PMID: 33711005.

2.073

7

5

Pattanaik S*, Jain A, Ahluwalia J.

 

Evolving Role of Pharmacogenetic Biomarkers to Predict the Risk of Drug-Induced Hematological Disorders.

 

Ther Drug Monit. 2021 Apr 1;43(2):201-220.

doi: 10.1097/FTD.0000000000000842.

 

PMID: 33235023.

2.073

0

0

Nanda Gamad, Ashish Kumar Kakkar, Smita Pattanaik*.

Efficacy of Anifrolumab in SLE: A Critical Analysis of TULIP trials.

Lupus 2020 Jul;29(8):1002-1003. doi: 10.1177/0961203320928425. Epub 2020 Jun 3.

PMID: 32493153

2.60

2

0

Smita Pattanaik*. Report on The Symposium Therapeutic Drug Monitoring of Immunosuppressants: Clinical Issues and Analytical Challenges. IATDMCT-COMPASS 2020; March:4-5.

NA

 

 

Dhir N, Attri SV, Pattanaik S*, Kumar MP, Gill NK, Patial A, Rathore N, Saha L, Mohindra S.

 

Aneurysmal Subarachnoid Hemorrhage: Impact on Phenytoin Permeability across the Blood-Brain Barrier.

 

Neurol India. 2020 May-Jun;68(3):588-592. doi: 10.4103/0028-3886.288987.

 

PMID: 32643669.

2.128

0

0

Garg G,Patil AN*,Kumar R,Bhatia A,Kasudhan KS,Pattanaik S

 

Protective role of Convolvulus Pluricaulis on lipid abnormalities in high-fat diet with low dose streptozotocin-induced experimental rat model.

 

J Ayurveda Integr Med. 2020 Oct-Dec;11(4):426-431. doi: 10.1016/j.jaim.2020.06.011. Epub 2020 Aug 17.

 

PMID: 32814671; PMCID: PMC7772484.

1.505

0

2

Pandey GS, Sharma A, Kenwar DB, Patil SS, Seth A, Kallepalli V, Rally S, Thakur V, Mandwar M, Pattanaik S, Kaur R, Singh S*.

Analysis of Organ Utilization From Deceased Organ Donation in India.

 

Transplant Proc. 2020 Jul-Aug;52(6):1647-1649. doi: 10.1016/j.transproceed.2020.02.134. Epub 2020 Jun 20.

 

PMID: 32576472.

0.784

0

2

Naithani P, Dey S, Attri SV, Patil A, Patial A, Singh S, Panwar R, Sivakumar SP, Singh S, Kenwar DB, Pattanaik S*, Sharma A.

 

Real-life Bioequivalence of Tacrolimus in Patients With Living-Related Donor De Novo Renal Transplantation: An Observational Study.

 

Transplant Proc. 2020 Jul-Aug;52(6):1715-1717. doi: 10.1016/j.transproceed.2020.03.017. Epub 2020 May 21.

 

PMID: 32448656.

0.784

0

5

M N, Patil AN*, Pattanaik S, Kaur A, Banerjee D, Grover S.

ABCB1 and DRD3 polymorphism as a response predicting biomarker and tool for pharmacogenetically guided clozapine dosing in Asian Indian treatment resistant schizophrenia patients.

Asian J Psychiatr. 2020 Feb;48:101918. doi: 10.1016/j.ajp.2019.101918. Epub 2019 Dec 26.

PMID: 31896438

2.529

1

19

Harish C, Belavigi D, Patil AN, Pattanaik S, Kakkar A, Kasudhan KS.  

Assessment of the Impact of Clinical Pharmacology Consultations Provided to Hospital Clinicians From the Drug Information Center-An Outcome Research in a Developing Country.

J Pharm Pract. 2019 Nov 14:897190019885256. doi: 10.1177/0897190019885256. Online ahead of print.

PMID: 31726905

0.418

0

0

Pattanaik S,Sharma A*,Kumar-MP,Singh S, Shetty V, Minz M.

 

Is the Pre-transplant C2 an Optimum Predictor of Post-transplant Dose for Tacrolimus in Renal Transplantation

Patients?

 

Int. J. Pharmacokinet. 2019;4(1) :

https://doi.org/10.4155/ipk-2019-0002

NA

 

 

Pattanaik S, Dey S, Jaiswal N, Rohilla R, Singh SK, Mandal AK, Mavuduru RS*.

 

Efficacy and safety of programmed cell death-1/programmed cell death ligand-1 inhibitors in advanced urothelial malignancy: A systematic review and meta-analysis.

 

Indian J Urol. 2019 Apr-Jun;35(2):101-115. doi: 10.4103/iju.IJU_357_18.

 

PMID: 31000914; PMCID: PMC6458809.

0.89

0

0

Pattanaik S, Kundal P, Mavuduru RS*, Singh SK, Mandal AK.

 

Endothelial Dysfunction in Patients With Erectile Dysfunction: A Double-Blind, Randomized-Control Trial Using Tadalafil.

 

Sex Med. 2019 Jan 9. pii: S2050-1161(18)30119-3. doi: 10.1016/j.esxm.2018.11.008.

 

PMID:30638829

1.923

8

0

Pattanaik S, Mavuduru RS*, Panda A, Mathew JL, Agarwal MM, Hwang EC, Lyon JA, Singh SK, Mandal AK.

 

Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia.

 

BJU Int. 2019 Jan 25. doi: 10.1111/bju.14689.

 

PMID:30681264

4.68

3

0

Pattanaik S ,Sandhu HS, Mavuduru RS, Singh SK, Mandal AK.

 

Evaluation of the effect of tamsulosin and tadalafil in relieving benign prostatic hyperplasia related symptoms: A randomized double blind placebo controlled cross-over study.

 

Indian J Urol 2019 Jan-Mar;35(1):25-33. doi: 10.4103/iju.IJU_147_18.

 

PMID:30692721

0.89

2

0

Naik BN, Mathew PJ, Pattanaik S, MuthukrishnanV, Puri GD.

 

Pharmacokinetic modeling of propofol in Indian children.

 

J Pharmacol Pharmacother 2019;10 (1):22-32.

-

-

 

Krishnamoorthy B, Dudeja S, Dutta S, Pattanaik S*.

 

Grand round: Therapeutic Drug Monitoring Persistent muscle twitching with phenobarbitone in a preterm neonate-Lack of response or manifestation of toxicity?

 

Ther Drug Monit. 2019 Feb 19. doi: 10.1097/FTD.0000000000000611. [Epub ahead of print]

 

PMID:30801567

2.09

2

1

Sharma J, Deb B,  ………………*.

 

Somatic Mutations Profile of a Young Patient With Metastatic Urothelial Carcinoma Reveals Mutations in Genes Involved in Ion Channels.

 

 Front Oncol 2019 May 29;9:435. doi: 10.3389/fonc.2019.00435. eCollection 2019

 

PMID: 31192134; PMCID: PMC6549525.

4.25

3

6

Pattanaik S, Mavuduru RS*, Panda A, Mathew JL, Agarwal MM, Hwang EC, Lyon JA, Singh SK, Mandal AK.

 

Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia.

 

Cochrane Database Syst Rev. 2018 Nov 16;11:CD010060. doi: 10.1002/14651858.CD010060.pub2.

 

PMID: 30480763; PMCID: PMC6517182

7.77

5

14

Pattanaik S*. Conclusions from Meta-analysis: Overtly Simple or Need Critical Analysis.

Arthritis and Rheumatology 2017 Aug;69(8):1704-1705. doi: 10.1002/art.40116. Epub 2017 Jun 14.

PMID: 28376274

7.4

9.586

(2019)

0

0

Cohen A, Pattanaik S, Kumar P, Bies RR, de Boer A, Ferro A, Gilchrist A, Isbister GK, Ross S, Webb AJ.

 

Organised crime against the academic peer review system.

 

Br J Clin Pharmacol  2016 Jun;81(6):1012-7. doi: 10.1111/bcp.12992 (in top 5 read articles during 2016 Altmetric score 412)

 

PMID: 27211251

3.87

11

345

Pattanaik S, Mavuduru RS, Panda A, Agarwal MM, Mathew JL, Singh SK, Mandal AK.

 

Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia.

 

Cochrane Database of Systematic Reviews 2012, Issue 1. Art No: CD010060.

DOI: 10.1002/14651858.CD010060.

PMID: 30480763

6.74

1

 

Pattanaik S, Malhotra S*, Sharma YP, Pandhi P. 

Comparison of alternate day atorvastatin treatment to daily treatment in maintaining LDL-Cholesterol targets in patients with variable coronary risk profile.

J Cardiovasc Pharmacol 2012 May;59(5):479-84.

doi: 10.1097/FJC.0b013e31824ba699.

 

PMID: 22569288

2.22

8

5

Pattanaik S,Malhotra S*, Sharma YP, Ahluwalia J, Bhalla A, Pandhi P.

Effect of cilostazol on platelet aggregation in patients with non-ST elevation acute coronary syndrome.

 

Int J Clin Pharmacol Ther. 2010 Feb; 48(2):93-102.

 

PMID: 20137761

1.29

8

 

Singh I, Shafiq N, Pandhi P, Reddy S, Pattanaik S, Sharma Yash Paul, Malhotra S.

 

Triple Antiplatelet Therapy Versus Dual Antiplatelet therapy in Patients undergoing Primary Percutaneous Coronary Intervention: An evidence-based approach to answering a clinical query.

 

Br J Clin Pharmacol. 2009 Jul;68(1):4-13

doi: 10.1111/j.1365-2125.2009.03402.x.

 

PMID: 19659998

3.84

30

 

Pattanaik S, Dhamija P, Malhotra S*, Pandhi P.

 

Evaluation of cost of treatment of drug related events in a tertiary care public sector hospital in Northern India: a prospective study.

 

Br J clin pharmacol  2009 Mar; 67(3): 363-69.

doi: 10.1111/j.1365-2125.2008.03346.x. Epub 2008 Dec 1.

 

PMID: 19523017

3.84

24

 

Pattanaik S, Hota D*, Prabhakar S, Kharbanda P, Pandhi P.

 

Pharmacokinetic Interaction of Single Dose of Piperine with Steady-state Carbamazepine in Patients of Epilepsy.

 

Phytother Res  2009 Sep;23(9):1281-6.

 

PMID: 19283724.

1.86

57

11

Hota D*, Bansal V, Pattanaik S.

 

Evaluation of ketamine, nimodipine, gabapentin and imipramine in partial sciatic nerve transection model of neuropathic pain in rat: an experimental study.

 

Methods Find Exp Clin Pharmacol. 2007 Sep;29(7):443-6.

 

PMID: 17982508

1.87

13

 

Shafiq N, Bhasin B, Pattanaik S, Pandhi P, Venkateshan SP, Singh M, Malhotra S*.

A meta-analysis to evaluate the efficacy of statins in children with familial hypercholesterolemia.

Int J Clin Pharmacol Ther. 2007 Oct;45(10):548-55. Erratum in: Int J Clin Pharmacol Ther. 2008 Jan;46(1):41.

PMID: 17966840

1.86

8

 

Pattanaik S, Hota D*, Prabhakar S, Kharbanda P, Pandhi P.

Effect of piperine on the steady-state pharmacokinetics of phenytoin in patients with epilepsy.

Phytother Res 2006; Aug; 20(8):683-6.

PMID: 16767797.

1.86

93

 

Gupta S, Kalra OP, Trivedi S, Agarwal RP, Pattanaik S, Maseeh A, Patel K, Kabra P, Prusty V.

Multicentric open labeled trial of fixed dose combination of antihypertensive drugs for the treatment of moderate to severe hypertension not controlled by monotherapy. 

Indian J Cardiol 2005; 8: 31-33

NA

-

 

Pattanaik S, Shafiq N, Mittal R, Malhotra S, Pandhi P.

 Pharmacovigillance awareness: a questionnaire based approach to evaluate and promote reporting of adverse drug reactions.

Bull PGI 2008; 42: 3-6.

NA

-

 

Pattanaik S, Pandhi P.

Pharmacological treatment of asthma in pregnancy.

Drug Bulletin 2007

NA

-

 

Pattanaik S, Shafiq N, Malhotra S. Pharmacovigillance.

Drug Bulletin 2006.

NA

-

 

Abstracts Published

#P839: ‘Stroke Home Care’ - A Mobile Application: Home Based Innovative Nursing Care Intervention Developed by Stroke Nurse: A need of the Time in Covid -19 Pandemic. Stroke 2021; 52 (Suppl 1), AP839-AP839

Kumar A, Khurana D*, Pattanaik S. Mobile Phone Application Based Post-Stroke Strategy.

International Journal of Stoke 2020;15(Suppl 1): 148-148

A Kumar, D Khurana, M Kumar, S Pattanaik, M Modi, S Kaur, M Nagi. Impact of Medical Application Based Post-Stroke Care Strategy (MAPSS) on Quality of Life and Care Giver Burden.

International Journal of Stroke 2020;15 (Suppl 1): 19-20

#WP451 Kumar A, Khurana D*, Pattanaik S, Kumar M, Modi M, Kaur S, et.al. “Development, Feasibility and Validation of “Stroke Home Care” Application in a Resource Limited Setting: A Proof of Concept Study”. Stroke. Feb 2020; 51:AWP451-AW451

 

PD17-10 Pharmacokinetic And Pharmacodynamic Study Of Propofol In Patients With Renal Impairment. Rachna Rohilla; Smita Pattanaik*; Preethy Joseph Mathew; Ravimohan Suryanarayana Mavuduru; Govardhan Dutt Puri; Arup Kumar Mandal.

 

Presented at the 17th International Congress of therapeutic Drug Monitoring and Clinical Toxicology on 22nd September 2019 at Foz do Iguaxzu , Brazil.

Oral ID - MP33. Moderated poster session. Real-life Bioequivalence of Tacrolimus in Patients with de novo Live Related Donor Renal Transplantation. Priyanka Naithani, Smita Pattanaik, Savita Verma Atri, Ajay Patial, Sumit Dey, Sheetal Bansal, Ritika Panwar, Shivakumar SP, Deepesh B Kenwar, Sarbpreet Singh, Ashish Sharma.

Presented at the 16th congress of the Asian Society of Transplantation and the  joint meeting of 30th Annual Conference of Indian Society of Organ Transplantation (ISOT) was held in New Delhi, India from 29th of September to 2nd of October 2019

# AS14-039: Kumar A, Khurana D, Kaur S, Ghai S, Modi M, Pattanaik S, et al. “Post Stroke complications and caregivers’ stress among stroke patients in a developing country” European Stroke Journal 2019, Vol. 4(1S) 3–95. DOI: 10.1177/2396987319845560

Presented at 5th European Stroke Organisation Conference (ESOC 2019), held in Milan, Italy on 22-24 May 2019

 

PD 17-10 Pattanaik S, Khan R, Mavuduru RS, Singh SK, Mandal AK. Efficacy and safety of Tamsulosin and Tolteridine in the management of ureteric stent related symptoms following ureteroscpic removal of stone: A randomized double blind placebo controlled cross-over study.

Presented at the Annual meeting of American Urology Association May 18-21 , 2018, San Francisco USA.

AM17-2802/532 Pattanaik S, Mavuduru RS*, Panda A, Mathew J, Agarwal M, Singh SK, Mandal AK.  Phosphodiesterase inhibitors for BPH-LUTS: Is the benefit worth it? European Urology Supplements , Volume 16 , Issue 3 , e920 - e921. doi: 10.1016/S1569-9056(17)30590-0http://dx.doi.org/10.1016/S1569-9056(17)30590-0 (2017/04/12)

Presented at the European Association of Urology Congress at London on 12th December 2017

IATDMCT Kyoto [P26-1-4] Sep 25, 2017, Symposium: Therapeutic Drug Monitoring in Asia.  Therapeutic Drug Monitoring in India. Smita Pattanaik (11:45AM-12:15PM)

https://confit.atlas.jp/guide/mobile-img/iatdmct2017/subject/S-6-3/pdf?key=gDKLr8eHdQYNh0rtJejGmweiuldomthm

IATDMCT Kyoto [P26-1-4] Sep 26, 2017, 12:30-1:30PM. Anticonvulsant Drugs. Development and validation of phenytoin quantification from human brain, CSF and plasma by liquid chromatography tandem mass spectrometry. Neha Dhir, Smita Pattanaik, Sandeep Mahindra, Savita Atri, Lekha Saha, S K Gupta

http://www.iatdmct2017.jp/pdf/IATDMCT2017_Poster_P26_0818.pdf

 

Smita Pattanaik*, Santosh Kumar, Sudheer Devana, Girdhar Bora, Shrawan Singh, Pinaki Dutta, Arup Mandal, Ravimohan Mavuduru, Subhajit Mandal. Role of Vitamin D deficiency in erectile dysfunction. Int J Urol 2016; 23: 1442-2042 (http://dx.doi.org/10.1111/iju.13149

Presented at the Asian Society of Urology meeting at Singapore in March 2016.

R Mavuduru*, G Bora, S Devana, S Pattanaik, S Singh, N Kakkar, S Kumar. Utility of restage TURBT in Indian Scenario. Int J Urol 2016; 23: 41-42

Presented at the Asian Society of Urology meeting at Singapore in March 2016.

MP-4320 Ravimohan Mavuduru*, Pawan Kundal, Smita Pattanaik, Shrawan Singh, Arup Mandal. Endothelial Dysfunction in Patients of Erectile Dysfunction Using Short-Term Low Dose Tadalafil : A Double Blind Randomized Control Trial J Urol 2015; Vol. 193(supplement 4) : e525

Presented at the American Urology Society meeting at New Orleans in May 2015

Smita Pattanaik, James C Ritchie. Dried Blood Spot Multiplex Immunosuppressant Assay on Pre-Impregnated Cards with Deuterated Internal Standards by LC-MS/MS. Can be accessed at  http://iatdmct2015.org/wp-content/uploads/2015/11/Abstractbook.pdf

Presented at the American Urology Society meeting at New Orleans in May 2015

POD-11-04 Evaluation of the effect of Tamsulosin and Tadalafil in relieving BPH LUTS symptoms: A Randomized, Double Blind Placebo Controlled Crossover study. Sandhu HS, Mavuduru RS, Pattanaik S, Singh SK, Mandal AK

 

Book Chapters

Kidney Biomarkers.  Editors Seema S. Ahuja and Brian Castillo.

Biomarkers in Essential Hypertension. Smita Pattanaik. Pages 247-288.  https://doi.org/10.1016/B978-0-12-815923-1.00008-0

©2020 Elsevier

Contemporary Issues in Biomedical Science: Futuristic Thought. Editor : R C Sobti. Emerging role of cannabinoid system modulators in treatment of cancer. Sheetal Singh, Smita Pattanaik, Shrawan K Singh, Ravimohan SM.

Under production

Springer

Biomarkers in Kidney Transplantation: Clinical Aspects and Laboratory Determinations. Editors: Smita Pattanaik and Ashish Sharma. Chapter-12 Biomarkers for Drug Development in Organ Transplantation. Smita Pattanaik and Teun Van Gelder.

Under production

Elsevier

Biomarkers in Kidney Transplantation: Clinical Aspects and Laboratory Determinations. Editors: Dr Smita Pattanaik, Dr Ashish Sharma Chapter 14 The Current Challenges, Unmet Needs and Future Directions. Smita Pattanaik and Teun Van Gelder

Under production

Elsevier

Book as Editor

Biomarkers in Kidney Transplantation: Clinical Aspects and Laboratory Determinations. Editors: Smita Pattanaik and Ashish Sharma.

Publishing agreement May 2020 – Tentative date of completion May 2022


Completed Research work submittedfor publication

 

1.       Dried Blood SpotMultiplex Immunosuppressant Assay by LC-MS/MS with Stably Labeled InternalStandard Pre-impregnated Cards .

2.      Effect of Anti-oxidant Treatment on Seminal Reactive Oxygen Speciesand Total Antioxidant Capacity in patients with Idiopathic Infertility.

3.      Evaluation Efficacy ofTamsulosin and Tolterodine in the Management of Ureteric Stent Related Symptoms:A Randomized, Double Blind, Placebo Controlled, Crossover Study.

4.      Evaluation of Pharmacokinetics and Pharmacodynamics of propofol inpatients with chronic kidney disease.

5.      Vitamin D deficiency andits association with erectile dysfunction.

6.      Medical Application based Post Stroke care Strategy forSurvivors and their caregivers (MAPSS): A Randomized Controlled Trial.

Contract with

Elsevier